home / stock / mcrpf / mcrpf quote
Last: | $0.73 |
---|---|
Change Percent: | 0.0% |
Open: | $0.73 |
Close: | $0.73 |
High: | $0.73 |
Low: | $0.73 |
Volume: | 3,000 |
Last Trade Date Time: | 07/12/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.73 | $0.73 | $0.73 | $0.73 | $0.73 | 3,000 | 07-12-2024 |
$0.682 | $0.682 | $0.682 | $0.682 | $0.682 | 250 | 07-02-2024 |
$0.7127 | $0.7127 | $0.7127 | $0.7127 | $0.7127 | 1,200 | 06-28-2024 |
$0.7598 | $0.7598 | $0.7598 | $0.7598 | $0.7598 | 1,200 | 06-24-2024 |
$0.8 | $0.8 | $0.8 | $0.8 | $0.8 | 3,000 | 06-20-2024 |
$0.7779 | $0.7779 | $0.7779 | $0.7779 | $0.7779 | 4,000 | 06-05-2024 |
$0.8477 | $0.85735 | $0.8477 | $0.85735 | $0.8477 | 8,000 | 05-21-2024 |
$0.93 | $0.93 | $0.93 | $0.93 | $0.93 | 2,000 | 05-09-2024 |
$0.88 | $0.88 | $0.88 | $0.88 | $0.88 | 2,000 | 05-02-2024 |
$0.7 | $0.7 | $0.7 | $0.7 | $0.7 | 2,000 | 04-17-2024 |
$0.8 | $0.8 | $0.8 | $0.8 | $0.8 | 2,000 | 04-11-2024 |
$0.8474 | $0.8474 | $0.8474 | $0.8474 | $0.8474 | 4,000 | 04-08-2024 |
$0.77616 | $0.77616 | $0.77616 | $0.77616 | $0.77616 | 2,000 | 04-04-2024 |
$0.84 | $0.84 | $0.84 | $0.84 | $0.84 | 1,000 | 04-01-2024 |
$0.8862 | $0 | $0.8862 | $0 | $0 | 23,500 | 03-25-2024 |
$0.8862 | $0.8862 | $0.8862 | $0.8862 | $0.8862 | 100,000 | 03-18-2024 |
$0.880453 | $0.880453 | $0.880453 | $0.880453 | $0.880453 | 1,061 | 03-11-2024 |
$0.786 | $0.82425 | $0.786 | $0.82425 | $0.786 | 15,100 | 03-07-2024 |
$0.971 | $0 | $0.971 | $0 | $0 | 10 | 03-04-2024 |
$0.971 | $0.971 | $0.971 | $0.971 | $0.971 | 350 | 02-23-2024 |
News, Short Squeeze, Breakout and More Instantly...
Microport Scientific Corp Company Name:
MCRPF Stock Symbol:
OTCMKTS Market:
SHANGHAI , Sept. 4, 2018 /PRNewswire/ -- MicroPort Scientific Corporation ("MicroPort®", HK:0853) announced today that the clinical trial results for its Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®") which conducted a multi-center, randomized c...
Firehawk® Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication In The Prestigious Medical Journal The Lancet Canada NewsWire SHANGHAI, Sept. 3, 2018 SHANGHAI , Sept. 3, 2018 /CNW/ -- MicroPort Scientific Corporation ("MicroP...